Adaptive Biotechnologies (ADPT) Other Accumulated Expenses (2018 - 2025)

Adaptive Biotechnologies (ADPT) has 8 years of Other Accumulated Expenses data on file, last reported at $826000.0 in Q4 2025.

• Quarterly Other Accumulated Expenses changed 0.48% year-over-year to $826000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $826000.0 (changed 0.48% YoY) and the FY2025 annual result came in at $826000.0, changed 0.48% from the prior year.
• Other Accumulated Expenses was little changed at $826000.0 in Q4 2025 per ADPT's latest filing, from $830000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.7 million in Q4 2022, with the low at $763000.0 in Q4 2023.
• Average Other Accumulated Expenses over 5 years is $1.0 million, with a median of $830000.0 recorded in 2024.
• Year-over-year, Other Accumulated Expenses jumped 58.52% in 2022 and sank 53.9% in 2023.
• Adaptive Biotechnologies' Other Accumulated Expenses stood at $1.0 million in 2021, then jumped by 58.52% to $1.7 million in 2022, then slumped by 53.9% to $763000.0 in 2023, then advanced by 8.78% to $830000.0 in 2024, then dropped by 0.48% to $826000.0 in 2025.
• Business Quant data shows ADPT's Other Accumulated Expenses at $826000.0 in Q4 2025, $830000.0 in Q4 2024, and $763000.0 in Q4 2023.